February 8, 2011
BILLERICA, MA, (February 8, 2011) – Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services announced that it has signed a letter of intent to enter into a diagnostic development collaboration with Peking University Cancer Hospital ("PUCH"), Beijing, China. The primary goal for the collaboration is to develop predictive diagnostic markers for [...]
Danaher to Acquire Beckman Coulter, Inc.
February 7, 2011
ORANGE COUNTY, Calif. - Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, and Danaher, a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers, announced today that they have entered into a [...]
Abbott’s Ibis Technology Identified Fatal Disease Organism in Afghanistan
February 7, 2011
WASHINGTON - Today, at the American Society for Microbiology Conference on Biodefense and Emerging Diseases, scientists from Abbott Molecular presented data showing the unique power of the company's Ibis technology to identify and further characterize unknown disease-causing pathogens to help aid in the bioforensic analysis of pandemic outbreaks. In a presentation at the conference, Tim [...]
Exiqon Announces 2011 Grant Program for MicroRNA Research
February 7, 2011
Copenhagen, Denmark - Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced that data from its diagnostic program on early detection of colorectal cancer in plasma has been selected for oral presentation at the 102nd Annual American Association for Cancer Research (AACR) Meeting to be held 2-6 April in Orlando, Florida. The presentation is scheduled to [...]
Pressure BioSciences, Inc. Unveils Four Key Instruments in Its 2011-2013 PCT Product Pipeline
February 7, 2011
South Easton, MA - Pressure BioSciences, Inc. (NASDAQ: PBIO) (“PBI” and the “Company”) today announced that it has unveiled four key instruments in its 2011-2013 product pipeline at the annual meeting of the Association for Mass Spectrometry Applications to the Clinical Lab (MSACL). Attended by physicians, scientists, and other healthcare professionals, MSACL is an active [...]
Particle Sciences and HORIBA Instruments Form Strategic Relationship
February 7, 2011
BETHLEHEM, Pa. - Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan. This alliance assures that both client bases are provided with a total solution, combining the [...]
Carl Zeiss Receives R&D Contract for Its Gas Field Ion Source (GFIS) Technology
February 7, 2011
PEABODY/Massachusetts - Carl Zeiss today announced that it has been awarded a $22.6 million contract to develop certain nano manufacturing and imaging applications based on its revolutionary ORION™ Gas Field Ion Source (GFIS) technology. The contract was awarded to US-based Carl Zeiss NTS, LLC by the Intelligence Advanced Research Projects Activity (IARPA) under the Circuit [...]
Danaher to Acquire Beckman Coulter, Inc. for $83.50 per share or $6.8 Billion
February 7, 2011
Washington, D.C. - Danaher Corporation (NYSE:DHR) announced today that it has entered into a definitive merger agreement with Beckman Coulter, Inc. (NYSE: BEC) pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase price of [...]
February 7, 2011
WASHINGTON - Bruker today announces the North American launch of its compact, fully automated and fast toxin identification system, called pTD(TM) (portable Toxin Detector), at the American Society for Microbiology (ASM) Bio-Defense and Emerging Diseases Research Meeting in Washington, DC. The novel, benchtop, push-button pTD system is intended for smaller, field and mobile laboratories for [...]
BD Announces Agreement to Acquire Accuri Cytometers, Inc.
February 7, 2011
Franklin Lakes, NJ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it signed a definitive agreement to acquire Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers. The acquisition is subject to regulatory approvals and is expected to [...]
